COMMENTARY: Yoav Keynan, MD and NCCID’s Scientific Lead COMMENT According to the WHO 2017 report, in 2016 globally, there were 600,000 new cases of tuberculosis with resistance to rifampicin, the most effective first-line drug, of which 490,000 cases had multidrug-resistant TB (MDR-TB), defined as resistance to rifampicin and isoniazid. Almost half (47%) of these cases…
Worldwide, antimicrobial resistance has emerged as a serious public health threat. Preserving the ability to use antimicrobials effectively for the future will require far-reaching responses. In this case study, we describe the processes and structures put in place by Alberta Health Services (AHS) to support and maintain coordinated antimicrobial stewardship programs in the province.
Roadmap for improving antimicrobial stewardship (AMS) in Canada and lays out a series of 10 areas for a national Action Plan on antimicrobial stewardship that focuses on AMS in the human health context, while recognizing the importance of action in agriculture and animal health as part of a “One Health” approach to AMS.
Report from June 2016 roundtable gathering over 50 experts, key influencers and stakeholders in the fields of antimicrobial stewardship and resistance to begin developing a Canadian multi-sectoral Antimicrobial Stewardship Action Plan, spanning hospital, long-term care and community settings.
Knowledge of the various contexts in which antimicrobials are used, such as human health, animal health, and agriculture, is required to get a complete picture of what is causing this unprecedented acceleration of resistance and what can be done to reverse it.
The authors conducted a review of peer-review literature and analyzed terminology usage. The intent of this document is to provide public health practitioners and policy makers across disciplines with a lexicon that can lead to consensus.